natgillin/translations-raw huggingface dataset:
Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances [2] sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.
Del A Priloge k Izvedbeni uredbi Komisije (EU) št. 540/2011 z dne 25. maja 2011 o izvajanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta glede seznama registriranih aktivnih snovi [2] določa aktivne snovi, ki se štejejo za odobrene v skladu z Uredbo (ES) št. 1107/2009.
The approvals of the active substances acetamiprid, alpha-cypermethrin, Ampelomyces quisqualis Strain: AQ 10, benalaxyl, bifenazate, bromoxynil, chlorpropham, desmedipham, etoxazole, Gliocladium catenulatum Strain: J1446, imazosulfuron, laminarin, mepanipyrim, methoxyfenozide, milbemectin, phenmedipham, Pseudomonas chlororaphis Strain: MA 342, quinoxyfen, S-metolachlor, tepraloxydim, thiacloprid, thiram and ziram will expire between 31 July 2014 and 30 November 2015.
Odobritve aktivnih snovi acetamiprid, alfa-cipermetrin, Ampelomyces quisqualis sev: AQ 10, benalaksil, bifenazat, bromoksinil, klorprofam, desmedifam, etoksazol, Gliocladium catenulatum sev: J1446, imazosulfuron, laminarin, mepanipirim, metoksifenozid, milbemektin, fenmedifam, Pseudomonas chlororaphis sev: MA 342, kvinoksifen, S-metolaklor, tepraloksidim, tiakloprid, tiram in ziram prenehajo veljati med 31. julijem 2014 in 30. novembrom 2015.
Applications have been submitted for the renewal of these active substances.
Predložene so bile vloge za podaljšanje odobritev teh aktivnih snovi.
As the requirements laid down in Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market [3] will apply to those active substances, it is necessary to allow sufficient time to complete the renewal procedure in accordance with that Regulation.
Ker se bodo za navedene aktivne snovi uporabljale zahteve iz Izvedbene uredbe Komisije (EU) št. 844/2012 z dne 18. septembra 2012 o opredelitvi določb, potrebnih za izvedbo postopka podaljšanja odobritve aktivnih snovi, kot je določeno z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet [3], je treba zagotoviti dovolj časa za zaključek postopka podaljšanja odobritev v skladu z navedeno uredbo.
Consequently, the approval of those active substances would be likely to expire before a decision has been taken on their renewal.
Zato je verjetno, da bodo odobritve navedenih aktivnih snovi prenehale veljati pred sprejetjem sklepa o njihovem podaljšanju.
It is therefore necessary to postpone the expiry of their approval periods.
Zato je iztek obdobij njihovih odobritev treba odložiti.
Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
Izvedbeno uredbo (EU) št. 540/2011 bi bilo zato treba ustrezno spremeniti.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where no supplementary dossier in accordance with Implementing Regulation (EU) No 844/2012 is submitted within 30 months before the respective expiry date laid down in the Annex to this Regulation, the Commission will set the expiry date at the same date as before this Regulation or at the earliest date thereafter.
Glede na cilj prvega odstavka člena 17 Uredbe (ES) št. 1107/2009 v zvezi s primeri, v katerih dopolnilna dokumentacija v skladu z Izvedbeno uredbo (EU) št. 844/2012 ni bila predložena v roku 30 mesecev pred ustreznim datumom izteka odobritve iz Priloge k tej uredbi, bo Komisija določila isti datum izteka kot pred to uredbo ali prvi možni datum po tem.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the adoption of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
Glede na cilj prvega odstavka člena 17 Uredbe (ES) št. 1107/2009 v zvezi s primeri, v katerih Komisija sprejme uredbo, ki določa, da se odobritev aktivne snovi iz Priloge k tej uredbi ne podaljša, ker merila za odobritev niso izpolnjena, Komisija določi isti datum izteka kot pred to uredbo ali na datum sprejetja Uredbe, če odobritev aktivne snovi ni podaljšana, odvisno od tega, kateri datum je poznejši.
OJ L 252, 19.9.2012, p. 26.
UL L 252, 19.9.2012, str. 26.
In the sixth column, expiration of approval, of entry 73, thiram, the date 31 July 2014 is replaced by 30 April 2017.
v šestem stolpcu vnosa 73 za tiram se datum veljavnosti registracije „31. julij 2014“ nadomesti s „30. april 2017“;
In sixth column, expiration of approval, of entry 74, ziram, the date 31 July 2014 is replaced by 30 April 2017.
v šestem stolpcu vnosa 74 za ziram se datum veljavnosti registracije „31. julij 2014“ nadomesti s „30. april 2017“;
In the sixth column, expiration of approval, of entry 82, quinoxyfen, the date 31 August 2014 is replaced by 30 April 2017.
v šestem stolpcu vnosa 82 za kvinoksifen se datum veljavnosti registracije „31. avgust 2014“ nadomesti s „30. april 2017“;
In the sixth column, expiration of approval, of entry 89, Pseudomonas chlororaphis Strain: MA 342, the date 30 September 2014 is replaced by 30 April 2017.
v šestem stolpcu vnosa 89 za Pseudomonas chlororaphis sev: MA 342 se datum veljavnosti registracije „30. september 2014“ nadomesti s „30. april 2017“;
In the sixth column, expiration of approval, of entry 90, mepanipyrim, the date 30 September 2014 is replaced by 30 April 2017.
v šestem stolpcu vnosa 90 za mepanipirim se datum veljavnosti registracije „30. september 2014“ nadomesti s „30. april 2017“;
In the sixth column, expiration of approval, of entry 91, acetamiprid, the date 31 December 2014 is replaced by 30 April 2017.
v šestem stolpcu vnosa 91 za acetamiprid se datum veljavnosti registracije „31. december 2014“ nadomesti s „30. april 2017“;
In the sixth column, expiration of approval, of entry 92, thiacloprid, the date 31 December 2014 is replaced by 30 April 2017.
v šestem stolpcu vnosa 92 za tiakloprid se datum veljavnosti registracije „31. december 2014“ nadomesti s „30. april 2017“;
In the sixth column, expiration of approval, of entry 78, chlorpropham, the date 31 January 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 78 za klorprofam se datum veljavnosti registracije „31. januar 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 83, alpha-cypermethrin, the date 28 February 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 83 za alfa-cipermetrin se datum veljavnosti registracije „28. februar 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 84, benalaxyl, the date 28 February 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 84 za benalaksil se datum veljavnosti registracije „28. februar 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 85, bromoxynil, the date 28 February 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 85 za bromoksinil se datum veljavnosti registracije „28. februar 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 86, desmedipham, the date 28 February 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 86 za desmedifam se datum veljavnosti registracije „28. februar 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 88, phenmedipham, the date 28 February 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 88 za fenmedifam se datum veljavnosti registracije „28. februar 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 93, Ampelomyces quisqualis Strain: AQ 10, the date 31 March 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 93 za Ampelomyces quisqualis sev: AQ 10 se datum veljavnosti registracije „31. marec 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 94, imazosulfuron, the date 31 March 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 94 za imazosulfuron se datum veljavnosti registracije „31. marec 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 95, laminarin, the date 31 March 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 95 za laminarin se datum veljavnosti registracije „31. marec 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 96, methoxyfenozide, the date 31 March 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 96 za metoksifenozid se datum veljavnosti registracije „31. marec 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 97, S-metolachlor, the date 31 March 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 97 za S-metolaklor se datum veljavnosti registracije „31. marec 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 98 Gliocladium catenulatum Strain: J1446, the date 31 March 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 98 za Gliocladium catenulatum sev: J1446 se datum veljavnosti registracije „31. marec 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 99, etoxazole, the date 31 May 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 99 za etoksazol se datum veljavnosti registracije „31. maj 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 100, tepraloxydim, the date 31 May 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 100 za tepraloksidim se datum veljavnosti registracije „31. maj 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 109, bifenazate, the date 30 November 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 109 za bifenazat se datum veljavnosti registracije „30. november 2015“ nadomesti z „31. julij 2017“;
In the sixth column, expiration of approval, of entry 110, milbemectin, the date 30 November 2015 is replaced by 31 July 2017.
v šestem stolpcu vnosa 110 za milbemektin se datum veljavnosti registracije „30. november 2015“ nadomesti z „31. julij 2017“.
Commission Implementing Regulation (EU) No 1198/2012
Izvedbena uredba Komisije (EU) št. 1198/2012
Commission Implementing Regulation (EU) No 1199/2012
Izvedbena uredba Komisije (EU) št. 1199/2012
The currently applicable refunds have been fixed by Commission Implementing Regulation (EU) No 858/2012 [4].
Zdaj veljavna nadomestila so bila določena z Izvedbeno uredbo Komisije (EU) št. 858/2012 [4].
Implementing Regulation (EU) No 858/2012 is hereby repealed.
Izvedbena uredba (EU) št. 858/2012 se razveljavi.
OJ L 255, 21.9.2012, p. 18.
UL L 255, 21.9.2012, str. 18.
Export refunds on eggs applicable from 14 December 2012
Izvozna nadomestila za jajca, ki se uporabljajo od 14. decembra 2012
Commission Implementing Regulation (EU) No 1200/2012
Izvedbena uredba Komisije (EU) št. 1200/2012
Commission Implementing Regulation (EU) No 1201/2012
Izvedbena uredba Komisije (EU) št. 1201/2012
Those prices and duties were last amended by Commission Implementing Regulation (EU) No 1103/2012 [4].
Navedene cene in uvozne dajatve so bile nazadnje spremenjene z Izvedbeno uredbo Komisije (EU) št. 1103/2012 [4].
OJ L 327, 27.11.2012, p. 22.
UL L 327, 27.11.2012, str. 22.
Amended representative prices and additional import duties applicable to white sugar, raw sugar and products covered by CN code 17029095 from 14 December 2012
Spremenjene reprezentativne cene in dodatne uvozne dajatve za beli in surovi sladkor ter proizvode z oznako KN 17029095, ki se uporabljajo od 14. decembra 2012
Commission Implementing Regulation (EU) No 1202/2012
Izvedbena uredba Komisije (EU) št. 1202/2012
The currently applicable refunds have been fixed by Commission Implementing Regulation (EU) No 861/2012 [3].
Trenutno veljavna nadomestila so bila določena z Izvedbeno uredbo Komisije (EU) št. 861/2012 [3].
Implementing Regulation (EU) No 861/2012 is hereby repealed.
Izvedbena uredba (EU) št. 861/2012 se razveljavi.
OJ L 255, 21.9.2012, p. 27.
UL L 255, 21.9.2012, str. 27.
Rates of the refunds applicable from 14 December 2012 to eggs and egg yolks exported in the form of goods not covered by Annex I to the Treaty
Stopnje nadomestil, ki se od 14. decembra 2012 uporabljajo za jajca in jajčne rumenjake, izvožene kot blago, ki ni zajeto v Prilogi I k Pogodbi
Commission Implementing Regulation (EU) No 1203/2012
Izvedbena uredba Komisije (EU) št. 1203/2012
on the separate sale of regulated retail roaming services within the Union
o ločeni prodaji reguliranih maloprodajnih storitev gostovanja v Uniji
Having regard to Regulation (EU) No 531/2012 of the European Parliament and of the Council of 13 June 2012 on roaming on public mobile communications networks within the Union [1], and in particular Article 5(2) thereof,
ob upoštevanju Uredbe (EU) št. 531/2012 Evropskega parlamenta in Sveta z dne 13. junija 2012 o gostovanju v javnih mobilnih komunikacijskih omrežjih v Uniji [1], zlasti člena 5(2) Uredbe,
After consulting the Body of European Regulators for Electronic Communications,
po posvetovanju z Organom evropskih regulatorjev za elektronske komunikacije,
Regulation (EU) No 531/2012 introduces the concept of separate sale of regulated retail roaming services.
Uredba (EU) št. 531/2012 je uvedla pojem ločene prodaje reguliranih maloprodajnih storitev gostovanja.
Firstly, Article 4(1) of Regulation (EU) No 531/2012 imposes an obligation on domestic providers to enable their customers to access regulated voice, SMS and data roaming services, provided as a bundle, by any alternative roaming provider.
Prvič, domači ponudniki so v skladu s členom 4(1) Uredbe (EU) št. 531/2012 obvezani, da svojim porabnikom zagotovijo dostop do reguliranih storitev govornega, SMS in podatkovnega gostovanja, ki jih alternativni ponudnik gostovanja ponuja v paketu.
Furthermore, the provisions on separate sale of regulated retail roaming services as laid down in Article 4(1) include the requirement for domestic providers and roaming providers not to prevent roaming customers from accessing regulated data roaming services provided directly on a visited network by an alternative roaming provider.
Poleg tega določbe o ločeni prodaji reguliranih maloprodajnih storitev gostovanja v členu 4(1) vključujejo zahtevo, da domači ponudniki in ponudniki gostovanja gostujočim porabnikom ne preprečijo dostopa do reguliranih storitev podatkovnega gostovanja, ki jih neposredno v obiskanem omrežju zagotavlja alternativni ponudnik gostovanja.
In order to ensure consistent and simultaneous implementation across the Union of the separate sale of regulated retail roaming services, Regulation (EU) No 531/2012 requires the Commission to adopt, by means of implementing acts, detailed rules on the information obligations about the possibility for roaming customers to opt for an alternative roaming provider and on a technical solution for the implementation of the separate sale of regulated retail roaming services.
Da se zagotovi skladno in istočasno izvajanje ločene prodaje reguliranih maloprodajnih storitev gostovanja po vsej Uniji, mora Komisija v skladu z Uredbo (EU) št. 531/2012 z izvedbenimi akti sprejeti podrobna pravila o obveznostih obveščanja gostujočih porabnikov o možnosti izbire alternativnega ponudnika gostovanja ter o tehnični rešitvi za izvajanje ločene prodaje reguliranih maloprodajnih storitev gostovanja.
In accordance with Article 5(4) of Regulation (EU) No 531/2012, the technical solution to implement the separate sale of regulated retail roaming services may combine one or more technical modalities for the purposes of meeting all the criteria set out in Article 5(3) of Regulation (EU) No 531/2012.
V skladu s členom 5(4) Uredbe (EU) št. 531/2012 lahko tehnična rešitev za izvajanje ločene prodaje reguliranih maloprodajnih storitev gostovanja za namene izpolnjevanja vseh meril iz člena 5(3) Uredbe (EU) št. 531/2012 združuje eno ali več tehnik.
Several technical modalities should therefore need to be implemented, if not all of these criteria can be met by only one technical modality.
Zato bi bilo treba morda izvajati več tehnik, če ena sama tehnika ne izpolnjuje vseh teh meril.
This Regulation should lay down detailed rules on this technical solution comprising the requirements for domestic providers to deploy network elements and to provide related services concerning each technical modality, in order to ensure access to these facilities necessary to allow alternative roaming providers to offer separate roaming services and to provide for the switching process between donor and recipient roaming providers.
Ta uredba bi morala določiti podrobna pravila o tej tehnični rešitvi, vključno z zahtevama za domače ponudnike, da vzpostavijo omrežne elemente in da za vsako tehniko zagotovijo s tem povezane storitve ter tako omogočijo dostop do teh zmogljivosti, ki so potrebne, da lahko alternativni ponudniki gostovanja ponudijo ločene storitve gostovanja ter zagotovijo preklapljanje med donatorskimi in sprejemnimi ponudniki gostovanja.
At the same time, the technical solution should make it possible to give effect to the obligations referred to in Article 4(1) of Regulation (EU) No 531/2012.
Obenem bi morala tehnična rešitev omogočati izpolnjevanje obveznosti iz člena 4(1) Uredbe (EU) št. 531/2012.
Therefore the technical solution should ensure both the possibility for customers to access regulated voice, SMS and data roaming services, provided as a bundle by any alternative roaming provider and that domestic providers and roaming providers comply with the obligation not to prevent customers from accessing regulated data roaming services provided directly on a visited network by an alternative roaming provider.
Zato bi morala tehnična rešitev zagotoviti, da imajo porabniki dostop do reguliranih storitev govornega, SMS in podatkovnega gostovanja, ki jih alternativni ponudnik gostovanja zagotavlja v paketu, ter da domači ponudniki in ponudniki gostovanja izpolnjujejo obveznost, da porabnikom ne preprečujejo dostopa do reguliranih storitev podatkovnega gostovanja, ki jih neposredno v obiskanem omrežju zagotavlja alternativni ponudnik gostovanja.
Currently all retail roaming services are provided together with domestic mobile communication services by the domestic provider.
Trenutno vse maloprodajne storitve gostovanja skupaj z domačimi mobilnimi komunikacijskimi storitvami zagotavlja domači ponudnik.
Regulation (EU) No 531/2012 enables the roaming customer to select an alternative roaming provider for regulated roaming services provided as a bundle and to acquire those roaming services separately from the domestic mobile services.
Uredba (EU) št. 531/2012 gostujočim porabnikom omogoča, da izberejo alternativnega ponudnika gostovanja, ki regulirane storitve gostovanja zagotavlja v paketu, ter da navedene storitve gostovanja pridobijo ločeno od domačih mobilnih storitev.
In this regard, the roaming customer concludes a contract with an alternative roaming provider for the provision of those services.
Pri tem gostujoči uporabnik z alternativnim ponudnikom gostovanja sklene pogodbo o zagotavljanju navedenih storitev.
There are several technical modalities to implement the separate sale of roaming services as a bundle, including dual International Mobile Subscriber Identity (dual-IMSI) (two separate IMSI on the same SIM card) and single IMSI (the sharing of one IMSI between the domestic and roaming providers).
Za izvajanje ločene prodaje storitev gostovanja v paketu obstaja več tehnik, med drugim dvojna mednarodna oznaka mobilnega naročnika (dvojna IMSI) (dve različni IMSI na isti kartici SIM) in enojna IMSI (souporaba IMSI med domačim in gostiteljskim ponudnikom).
The dual IMSI technical modality is based on a second profile on the roaming customer’s SIM card that can be used by the alternative roaming provider for the sale of regulated roaming services, while the first profile is still used by the domestic provider for the sale of domestic services and possibly non-regulated roaming services.
Tehnika dvojne IMSI temelji na drugem profilu kartice SIM gostujočega porabnika, ki jo lahko alternativni ponudnik gostovanja uporabi za prodajo reguliranih storitev gostovanja, medtem ko prvi profil še vedno uporablja domači ponudnik za prodajo domačih storitev in morebitnih nereguliranih storitev gostovanja.
Under the single IMSI technical modality the separate roaming services are technically still provided by the domestic provider, which serves as the host mobile network operator to the alternative roaming provider.
Pri tehniki enojne IMSI ločene storitve gostovanja tehnično še vedno zagotavlja domači ponudnik, ki je za alternativnega ponudnika gostovanja operater gostiteljskega mobilnega omrežja.
The separate roaming services are provided on a wholesale basis to the alternative roaming provider, which resells the services to the roaming customer at retail level.
Ločene storitve gostovanja se alternativnemu ponudniku gostovanja zagotavljajo na veleprodajni ravni, ta pa jih na maloprodajni ravni proda naprej gostujočemu porabniku.
The most basic version is a pure resale option.
Najosnovnejša možnost je čista poprodaja.
Furthermore, there are a number of potential enhancements to the pure resale technical modality that enable the alternative roaming provider to control which visited networks are to be used preferably and to recover discounts on the wholesale roaming services purchased from the host mobile network operator (MNO) based on wholesale agreements with visited network operators or wholesale aggregators.
Poleg tega je čisto poprodajno tehniko mogoče izboljšati na več načinov, ki alternativnim ponudnikom gostovanja omogočajo, da nadzorujejo, katera obiskana omrežja naj se uporabljajo prednostno, ter da na veleprodajni ravni dosežejo popuste za storitve gostovanja, ki jih od operaterja gostiteljskega mobilnega omrežja kupijo na podlagi veleprodajnih sporazumov z operaterji obiskanih omrežij ali veleprodajnimi agregatorji.
In accordance with Article 5(1) of Regulation (EU) No 531/2012, access to the network elements and services necessary for the separate sale of regulated retail roaming services should be provided free of charge.
V skladu s členom 5(1) Uredbe (EU) št. 531/2012 bi se moral dostop do omrežnih elementov in storitev, potrebnih za ločeno prodajo reguliranih maloprodajnih storitev gostovanja, zagotavljati brezplačno.
Consequently, pricing of any additional services which go beyond what is necessary for the separate sale of regulated retail roaming services is not covered by Article 5(1).
Zato člen 5(1) ne ureja oblikovanja cen dodatnih storitev, ki presegajo to, kar je potrebno za ločeno prodajo reguliranih maloprodajnih storitev gostovanja.
Access to facilities and support services for the separate sale of regulated retail roaming services includes the facilities and services needed in the process of switching a customer.
Dostop do zmogljivosti in podpornih storitev za ločeno prodajo reguliranih maloprodajnih storitev gostovanja vključuje tudi zmogljivosti in storitve, potrebne za preklop porabnika.
The Body of European Regulators for Electronic Communications (‘BEREC’) has carried out its expert assessment on the solutions to implement separate roaming services [2].
Organ evropskih regulatorjev za elektronske komunikacije (BEREC) je strokovno ocenil rešitve za izvajanje ločenih storitev gostovanja [2].